Reisinger, Alexander C. http://orcid.org/0000-0002-5773-5695
Hatzl, Stefan
Prattes, Juergen
Hackl, Gerald
Schilcher, Gernot
Eisner, Florian
Niedrist, Tobias
Raggam, Reinhard
Krause, Robert
Eller, Philipp
Funding for this research was provided by:
Medical University of Graz
Article History
Received: 15 August 2023
Accepted: 26 October 2023
First Online: 16 November 2023
Declarations
:
: Krause R received investigator initiated research grants from Merck and Pfizer and served as a speaker for Pfizer, Gilead, Astellas, Basilea, Merck and Angelini. The other authors report no conflict of interest or financial disclosures.
: The study protocol was approved by the Institutional Review Board of the Medical University of Graz, Austria (32-472 ex 19/20), registered in the WHO approved German study registry (DRKS00022458) and complied with the Declaration of Helsinki.
: Written informed consent was obtained from all conscious patients. In comatose non-survivors, the IRB waived the need for informed consent.